Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov;354(11):e2100062.
doi: 10.1002/ardp.202100062. Epub 2021 Jun 29.

Azetidines of pharmacological interest

Affiliations
Review

Azetidines of pharmacological interest

Deepa R Parmar et al. Arch Pharm (Weinheim). 2021 Nov.

Abstract

Azetidines are almost unexplored among nitrogen-containing saturated heterocycles due to difficulties associated with their synthesis. However, over the past few years, attempts have been made by scientists to advance their synthetic feasibility. Compounds with the azetidine moiety display an important and diverse range of pharmacological activities, such as anticancer, antibacterial, antimicrobial, antischizophrenic, antimalarial, antiobesity, anti-inflammatory, antidiabetic, antiviral, antioxidant, analgesic, and dopamine antagonist activities, and are also useful for the treatment of central nervous system disorders and so forth. Owing to its satisfactory stability, molecular rigidity, and chemical and biological properties, azetidine has emerged as a valuable scaffold and it has drawn the attention of medicinal researchers. The present review sheds light on the traditional method of synthesis of azetidine and advancements in synthetic methodology over the past few years, along with its application with various examples, and its biological significance.

Keywords: Alzheimer's disease; analgesic activity; anticancer activity; aza Paternò-Büchi reaction; azetidine; dopamine receptors; fungicidal activity; pharmacological activities; recent development; ring strain.

PubMed Disclaimer

References

REFERENCES

    1. Z. Hosseinzadeh, A. Ramazani, N. Razzaghi-Asl, Curr. Org. Chem. 2018, 22, 2256.
    1. N. Kerru, L. Gummidi, S. Maddila, K. K. Gangu, S. B. Jonnalagadda, Molecule 2020, 25, 1909.
    1. D. Antermite, L. Degennaro, R. Luisi, Org. Biomol. Chem. 2017, 15, 34.
    1. F. Couty, G. Evano, Synlett 2009, 19, 3053.
    1. B. G. Rao, A. V. G. S. Prasad, P. V. Rao, Int. J. Innov. Res. Dev. 2013, 2, 72.

LinkOut - more resources